Successful treatment with colestimide for a bout of cholestasis in a Japanese patient with benign recurrent intrahepatic cholestasis caused by ATP8B1 mutation

Internal Medicine

Volumn 47, Issue 7, 2008, Pages 599-602

  Uegaki, Satoko ^a   Tanaka, Atsushi ^a   Mori, Yosuke ^a   Kodama, Hiroko ^a   Fukusato, Toshio ^a   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BRIC; Cholestasis; Colestimide; FICI

Indexed keywords

ADENINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); ARGININE; BILE ACID; BILIRUBIN; COLESTILAN; CYTOSINE; FARNESOID X RECEPTOR; GENOMIC DNA; GUANINE; HISTAMINE; PROTEIN ATP8B1; URSODEOXYCHOLIC ACID; ADENOSINE TRIPHOSPHATASE; ATP8B1 PROTEIN, HUMAN; EPICHLOROHYDRIN; IMIDAZOLE DERIVATIVE; RESIN;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DNA EXTRACTION; EXON; FEMALE; GENE AMPLIFICATION; HETEROZYGOSITY; HOSPITAL ADMISSION; HUMAN; HYPERBILIRUBINEMIA; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC CHOLESTASIS; JAPANESE; LIVER BIOPSY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SEQUENCE ANALYSIS; TREATMENT OUTCOME; ASIAN; CHOLESTASIS; GENETICS; MUTATION;

ADENOSINE TRIPHOSPHATASES; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTASIS; CHOLESTASIS, INTRAHEPATIC; EPICHLOROHYDRIN; FEMALE; HUMANS; IMIDAZOLES; MUTATION; RECURRENCE; RESINS, SYNTHETIC; TREATMENT OUTCOME;

EID: 44849098702     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0534     Document Type: Article

References (10)

1. Luketic V, Shiffman A Benign recurrent intrahepatic cholestasis. Clin Liver Dis 8: 133-149, 2004.
2. Bull L, van Eijk M, Pawlikowska L, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18: 219-224, 1998.
3. Chen F, Ananthanarayanan M, Emre S, et al, Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 126: 756-764, 2004.
4. Frankenberg T, Chen F, LA X, et al. FIC1 (ATP8B1) mediates protein kinase dependent phosphorylation and nuclear targeting of the farnesoid X-receptor. Hepatology 44: 240A, 2006.
5. Bijleveld C, Vonk R, Kuipers F, Havinga R, Fernandes J. Benign recurrent intrahepatic cholestasis: a long-term follow-up study of two patients. Hepatology 9: 532-537, 1989.
6. van Mil S, van der Woerd W, van der Brugge G, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 127: 379-384, 2004.
7. Nagasaka H, Chiba H, Hui S, et al. Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 45: 96-105, 2007.
8. Kitani K, Kanai S. Tauroursodeoxycholate prevents taurocholate induced cholestasis. Life Sci 30: 515-523, 1982.
9. Tsukahara. K, Kanai S, Ohta M, Kitani K. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats. Liver 13: 262-269, 1993.
10. Beuers U, Bilzer M, Chittattu A, et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33: 1206-1216, 2001.